Safety and Tolerability of Secukinumab in Patients with Active Ankylosing Spondylitis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials

被引：0
|
作者：
Deodhar, Atul A. [1 ]
Baeten, Dominique [2 ]
Sieper, Joachim [3 ]
Porter, Brian [4 ]
Widmer, Albert [5 ]
Richards, Hanno [5 ]
机构：
[1] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA
[2] Univ Amsterdam, Acad Med Ctr, Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Clin Benjamin Franklin, Berlin, Germany
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
SIGNIFICANTLY IMPROVES SIGNS; PLACEBO-CONTROLLED TRIAL; MONOCLONAL-ANTIBODY; INTERLEUKIN-17A; SYMPTOMS; PHASE-3;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2887
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials
    Kyburz, D.
    Deodhar, A.
    Baeten, D.
    Sieper, J.
    Porter, B.
    Widmer, A.
    Richards, H.
    SWISS MEDICAL WEEKLY, 2016, 146 : 6S - 6S
  • [2] SAFETY AND TOLERABILITY OF SECUKINUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POOLED SAFETY ANALYSIS OF TWO INTERNATIONAL PHASE 3, RANDOMIZED, CONTROLLED TRIALS
    Deodhar, Atul
    Baeten, Dominique
    Sieper, Joachim
    Porter, Brian
    Richards, Hanno
    Widmer, Albert
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 139 - 140
  • [3] SECUKINUMAB SAFETY AND TOLERABILITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED SAFETY ANALYSIS OF TWO PHASE 3, RANDOMIZED, CONTROLLED TRIALS (FUTURE 1 AND FUTURE 2)
    Mease, P.
    McInnes, I. B.
    Richards, H.
    Pricop, L.
    Widmer, A.
    Mpofu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 870 - 871
  • [4] Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3
    Karel Pavelka
    Alan Kivitz
    Eva Dokoupilova
    Ricardo Blanco
    Marco Maradiaga
    Hasan Tahir
    Luminita Pricop
    Mats Andersson
    Aimee Readie
    Brian Porter
    Arthritis Research & Therapy, 19
  • [5] Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3
    Pavelka, Karel
    Kivitz, Alan
    Dokoupilova, Eva
    Blanco, Ricardo
    Maradiaga, Marco
    Tahir, Hasan
    Pricop, Luminita
    Andersson, Mats
    Readie, Aimee
    Porter, Brian
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [6] SECUKINUMAB SAFETY AND TOLERABILITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PSORIASIS: RESULTS FROM A POOLED SAFETY ANALYSIS OF SEVEN INTERNATIONAL PHASE 3 TRIALS
    Soriano, Enrique
    Gottlieb, Alice
    McInnes, Ian B.
    Mease, Philip
    Mpofu, Shephard
    Widmer, Albert
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 140 - 140
  • [7] Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies
    Wei, James C. -C.
    Baeten, Dominique
    Sieper, Joachim
    Deodhar, Atul
    Bhosekar, Vaishali
    Martin, Ruvie
    Porter, Brian
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (05) : 589 - 596
  • [8] Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
    Sticherling, Michael
    Nikkels, Arjen F.
    Hamza, Ashraf M.
    Kwong, Pearl
    Szepietowski, Jacek C.
    El Sayed, Mahira
    Ghislain, Pierre-Dominique
    Khotko, Alkes A.
    Patekar, Manmath
    Ortmann, Christine-Elke
    Forrer, Pascal
    Papanastasiou, Philemon
    Keefe, Deborah
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 821 - 835
  • [9] Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
    Michael Sticherling
    Arjen F. Nikkels
    Ashraf M. Hamza
    Pearl Kwong
    Jacek C. Szepietowski
    Mahira El Sayed
    Pierre-Dominique Ghislain
    Alkes A. Khotko
    Manmath Patekar
    Christine-Elke Ortmann
    Pascal Forrer
    Philemon Papanastasiou
    Deborah Keefe
    American Journal of Clinical Dermatology, 2023, 24 : 821 - 835
  • [10] A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
    Irene van der Horst-Bruinsma
    Corinne Miceli-Richard
    Juergen Braun
    Helena Marzo-Ortega
    Karel Pavelka
    Alan J. Kivitz
    Atul Deodhar
    Weibin Bao
    Brian Porter
    Effie Pournara
    Rheumatology and Therapy, 2021, 8 : 1775 - 1787
12345